Genetics and genomics of melanoma.

Expert Review of Dermatology
Papia Ghosh, Lynda Chin

Abstract

The rapidly increasing incidence of melanoma, coupled with its highly aggressive metastatic nature, is of urgent concern. In order to design rational therapies, it is of critical importance to identify the genetic determinants that drive melanoma formation and progression. To date, signaling cascades emanating from the EGF receptor, c-MET and other receptors are known to be altered in melanoma. Important mutations in signaling molecules, such as BRAF and N-RAS, have been identified. In this review, some of the major genetic alterations and signaling pathways involved in melanoma will be discussed. Given the great deal of genetic heterogeneity observed in melanoma, it is likely that many more genetic determinants exist. Through the use of powerful genomic technologies, it is now possible to identify these additional genetic alterations in melanoma. A critical step in this analysis will be culling bystanders from functionally important drivers, as this will highlight genetic elements that will be promising therapeutic targets. Such technologies and the important points to consider in understanding the genetics of melanoma will be reviewed.

References

Nov 1, 1989·The American Journal of Surgical Pathology·K J SmithJ H Graham
May 1, 1986·British Journal of Cancer·G J DraperJ E Kingston
Aug 9, 1995·International Journal of Cancer. Journal International Du Cancer·D FordA Osterlind
Sep 1, 1994·Nature Genetics·C J HussussianN C Dracopoli
Feb 1, 1994·Melanoma Research·A P AlbinoN K Hayward
Oct 21, 1993·International Journal of Cancer. Journal International Du Cancer·J S CastresanaR L Barnhill
May 1, 1994·The Journal of Investigative Dermatology·J LübbeP Kleihues
Nov 14, 1997·Genes & Development·L ChinR A DePinho
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·G P RobertsonW K Cavenee
Aug 11, 1998·Nature Genetics·A Di CristofanoP P Pandolfi
Aug 12, 1998·The Journal of Investigative Dermatology·J M GrichnikC R Shea
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·K PodsypaninaR Parsons
Mar 10, 1999·Journal of the National Cancer Institute·J AitkenN Hayward
Apr 29, 1999·The New England Journal of Medicine·B A GilchrestM Yaar
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Sep 12, 2000·The American Journal of Pathology·B C BastianD Pinkel
Mar 10, 2001·Molecular and Cellular Biology·N BardeesyL Chin
May 4, 2001·Internal Medicine·R FukudaY Kinoshita
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchA Morabito
Sep 21, 2001·Nature·F P NoonanG Merlino
Nov 14, 2001·Lancet·A T van OosteromUNKNOWN European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Mingjian James YouRonald A DePinho
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jun 28, 2002·Cancer Cell·Ashani T WeeraratnaJeffrey M Trent
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Nov 26, 2002·Nature Genetics·Pamela M PollockPaul S Meltzer
Jan 17, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Allan T van OosteromUNKNOWN European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Mar 6, 2003·Human Mutation·Julie LangRona MacKie
Jun 6, 2003·Oncogene·Heng WuFrank G Haluska

❮ Previous
Next ❯

Citations

Jan 26, 2011·Annual Review of Pathology·Shu Liu, Steven D Leach
Jul 10, 2012·Nature Cell Biology·Olga ShakhovaLukas Sommer
Mar 10, 2015·Translational Oncology·Stephen A RosenbergJames S Goydos
Dec 15, 2015·Melanoma Research·Viktória KoroknaiMargit Balázs
Jun 30, 2010·The Journal of Thoracic and Cardiovascular Surgery·Jacob A KlapperDavid S Schrump
Oct 19, 2011·Pigment Cell & Melanoma Research·Rachel E Bell, Carmit Levy
Apr 5, 2013·Journal of Cellular Biochemistry·Jiezhong ChenXu Dong Zhang
Nov 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Scott E Woodman, Gordon B Mills
Jan 31, 2017·The American Journal of Dermatopathology·Ricardo HsiehSilvia V Lourenço
May 26, 2010·Annals of Surgical Oncology·Fushi WenJiaqi Shi
Aug 29, 2012·Oncogene·Y YangJ T Celebi
Jun 8, 2012·Nature Communications·Frances P NoonanEdward C De Fabo
Jan 16, 2014·The American Journal of Dermatopathology·Silvia V LourençoMarcello M S Nico
Jul 23, 2014·The American Journal of Dermatopathology·Paula C F SanchezCyro F Neto
May 30, 2015·PloS One·Ekaterina D BadaevaBenjamin Kilian
Nov 27, 2018·PLoS Genetics·María Angélica Bravo NúñezSarah E Zanders

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved